Bret L. Bostwick
MD, FAAP, FACMG, Venture Advisor at Breyer Capital
About
Bret is a physician-scientist and drug developer with expertise in drug discovery, clinical development, and translational medicine. Since 2019, he has been at Alnylam Pharmaceuticals where he co-invented CNS-targeted RNAi therapeutics, and he leads Translational Medicine Solutions, an advisory firm at the intersection of healthcare, technology, and venture capital.
Colleagues at Breyer Capital
Daniel Breyer
Partner at Breyer Capital
George Sard
Investor at Breyer Capital
Leo Grady
CEO in Residence - Founder/CEO of Jona Health at Breyer Capital
Morgan Cheatham
Partner and Head of Healthcare and Life Sciences at Breyer Capital
Samuel J. Palmisano
Venture Advisor at Breyer Capital
Ted Breyer
Partner at Breyer Capital